The Cheapest GLP-1 Medication in 2026
Below are the lowest realistic cash-pay monthly prices for every FDA-approved GLP-1, ranked cheapest-to-priciest. Insurance copays vary by plan and are shown separately for each drug. Updated May 2026.
$1,788/year for 14.7% peak weight loss.
Get Foundayo (orforglipron) via LillyDirect →Every GLP-1 ranked by cheapest cash-pay price
How we calculate $/lb lost:12-month projection at a 230 lb starting weight (the average phase-3 trial baseline) using each drug's published peak weight loss percentage and trial-fitted curve. Your actual $/lb depends on your starting weight, adherence, and dose escalation - run your own numbers on the calculator.
5 ways to get your GLP-1 cheaper
- Try LillyDirect or NovoCare first. Manufacturer self-pay programs are often cheaper than telehealth - LillyDirect Zepbound vials start at $299/mo.
- Apply for the manufacturer savings card. Wegovy and Zepbound both have commercial-insurance savings cards that can drop your copay to $0–$25.
- Get a comorbidity documented. Sleep apnea, hypertension, prediabetes, high cholesterol - any of these plus BMI ≥27 typically qualifies you for insurance coverage.
- Switch to a covered drug class.If your insurance covers Ozempic but not Wegovy, and you have type 2 diabetes, that's a valid path. Same molecule.
- Use telehealth as a last resort. Hims, Ro, Found and others offer $199–$499/mo. Compounded options (when available) are cheapest but FDA-restricted post-2025.
Frequently asked questions
What is the absolute cheapest GLP-1 in 2026?
On a sticker-price basis, compounded semaglutide via Hims at around $199/month is the cheapest legal channel for any GLP-1 when supply is available. For branded drugs (no compounded gray area), two paths tie at $149/month: Foundayo (orforglipron) via LillyDirect for the 0.8 mg lowest dose, and oral Wegovy 25mg via NovoCare for the lower titration doses. Both are first-line cash-pay options in 2026. Zepbound vials via LillyDirect at $299/month for the 2.5mg starter dose come next. The cheapest insurance-covered path on most commercial plans is $0-$25 per fill via the manufacturer Savings Card, but only if your plan covers the drug.
Is "cheapest" the same as "best value"? What does cost-per-pound mean?
No. The cheapest sticker price drug is not always the best value. Cost-per-pound-lost normalizes the price by expected efficacy. Tirzepatide (Zepbound) costs more per month than semaglutide (Wegovy) but produces about 50% more weight loss in trials, often making it cheaper per pound lost despite the higher monthly cost. Use the cost-per-pound column in the comparison table on this page to find your actual best deal, which often differs from the cheapest monthly cost.
Why are GLP-1 prices so different across telehealth platforms for the same drug?
Three reasons. First, branded versus compounded: a brand-name Wegovy from Hims costs ~$449/month while compounded semaglutide from the same platform is ~$199/month (different molecule manufacturer, different supply chain). Second, subscription tier: Novo Nordisk's subscription program priced through Hims/Ro/LifeMD is $249/month on a 12-month plan but $329/month on a 3-month plan. Third, bundling: Ro Body Program and Found include coaching plus the drug, which raises the total but is sometimes cheaper than buying drug + coaching separately.
Is compounded semaglutide or tirzepatide cheaper than branded - and is it still legal in 2026?
Compounded was historically 30-60% cheaper than branded. Legal status narrowed significantly in 2025-2026: FDA ended enforcement discretion for 503B outsourcing facilities (March 2025) and 503A pharmacies (February 2025) after the official shortages were resolved. On April 30, 2026, FDA proposed adding semaglutide and tirzepatide to the 503B Bulks List exclusion. 503A retains a narrow individual-patient exception (documented allergy or specific clinical justification - cost savings alone does not qualify). Hims and Ro have largely shifted to branded as a result, narrowing the price gap.
Can I switch from a more expensive GLP-1 to a cheaper one mid-treatment?
Yes, with a prescriber's approval. Common switches: from Wegovy (~$329-$449/mo branded telehealth) to oral Wegovy 25mg (~$149-$199/mo via NovoCare) for patients who tolerate semaglutide well at lower doses. From Mounjaro to Zepbound (same active ingredient tirzepatide, but Zepbound is weight-loss-indicated and has the LillyDirect $299-$449 vial path that Mounjaro does not). From compounded semaglutide to branded if compounded becomes unavailable. Expect 1-2 weeks of paperwork during the switch, and your prescriber may want a brief washout or dose adjustment between drugs.
What is the cheapest insurance-covered GLP-1?
If your commercial insurance covers the drug AND you qualify for the manufacturer Savings Card, the answer is $0-$25 per fill for any of: Wegovy, Zepbound, Foundayo, Mounjaro, Saxenda, or Ozempic. The catch: most plans require a BMI threshold (typically 30, or 27 with a weight-related comorbidity) plus prior authorization, and the savings card excludes Medicare/Medicaid/VA/Tricare patients by federal anti-kickback statute. If your plan does not cover the drug at all, the savings card cannot help. Foundayo and Zepbound both have a "non-covered benefit" path on their cards that still offers reduced pricing even when your insurance excludes the drug. Check your specific plan's Summary of Benefits before assuming coverage.
Why does Mounjaro cost more than Zepbound when they are the same drug?
Mounjaro and Zepbound both contain tirzepatide as the active ingredient, but they are FDA-approved for different indications (Mounjaro for type 2 diabetes, Zepbound for weight loss) and Eli Lilly prices them differently. Specifically: Zepbound has the LillyDirect self-pay vial program at $299-$449/month; Mounjaro does not - Mounjaro self-pay typically runs $499-$1,000+/month depending on channel. If you are using either drug for weight loss without a diabetes diagnosis, Zepbound is almost always the cheaper path.
How often do GLP-1 prices change? Is the data on this page current?
Manufacturer self-pay prices (LillyDirect, NovoCare) update quarterly or with new program announcements. Telehealth platform pricing changes more frequently - typically when a platform adjusts its subscription tiers or when supply dynamics shift. Insurance copays and formulary tiers reset annually with each plan year (typically January). The data on this page is verified monthly. Last verification: May 2026.
See also
- → How to Get Wegovy Without Insurance - every cash-pay path for Wegovy specifically
- → How to Get Zepbound Without Insurance - LillyDirect self-pay vials, telehealth, compounded tirzepatide
- → How to Get Mounjaro Without Insurance - and why most cash-pay patients should switch to Zepbound
- → How to Get Ozempic Without Insurance - and why most cash-pay patients should switch to Wegovy
- → Tirzepatide Cost (Every Channel) - molecule-level guide: Mounjaro, Zepbound, compounded
- → Saxenda Cost (And Whether It Is Still Worth It) - older daily injection vs newer once-weekly options
- → GLP-1 Savings Cards Compared - manufacturer copay reduction programs across all 4 major drugs
- → Telehealth Provider Comparison - Hims, Ro, Found, Lemonaid, LifeMD, GoodRx Care side-by-side
🔔 Get GLP-1 price-change alerts
GLP-1 prices move fast - LillyDirect dropped Zepbound vials twice in 2025. We'll email within 24 hours when manufacturer self-pay, telehealth, or insurance pricing changes. 1–3 alerts/month.